Home | About IPJ | Editorial board | Ahead of print | Current Issue | Archives | Instructions | Contact us |   Login 
Industrial Psychiatry Journal
Search Articles   
    
Advanced search   
 
This article has been cited by
1Current and up-and-coming pharmacotherapy for obsessive-compulsive disorder in adults
Giacomo Grassi,Stefano Pallanti
Expert Opinion on Pharmacotherapy.2018;19(14)1541
[DOI]
2The Glutamate and the Immune Systems: New Targets for the Pharmacological Treatment of OCD
Donatella Marazziti,Umberto Albert,Federico Mucci,Armando Piccinni
Current Medicinal Chemistry.2019;25(41)5731
[DOI]
3The Neuronal Glutamate Transporter EAAT3 in Obsessive-Compulsive Disorder
Angélica P. Escobar,Jens R. Wendland,Andrés E. Chávez,Pablo R. Moya
Frontiers in Pharmacology.2019;10(41)5731
[DOI]
4L-carnosine as an adjuvant to fluvoxamine in treatment of obsessive compulsive disorder: A randomized double-blind study
Somaye Arabzadeh,Maryam Shahhossenie,Bita Mesgarpour,Farzin Rezaei,Mohammad Reza Shalbafan,Zahra Ghiasi,Shahin Akhondzadeh
Human Psychopharmacology: Clinical and Experimental.2017;32(4)e2584
[DOI]
5Addressing the Complexity of Tourette's Syndrome through the Use of Animal Models
Ester Nespoli,Francesca Rizzo,Tobias M. Boeckers,Bastian Hengerer,Andrea G. Ludolph
Frontiers in Neuroscience.2016;10(4)e2584
[DOI]
6Beyond Depression: Ketamine and Glutamatergic Agents for PTSD, OCD, and Other Potential Applications
John W. Dougherty,Marc F. Ettensohn,Steven P. Levine
Psychiatric Annals.2018;48(4)184
[DOI]
7A systematic review and meta-analysis: Memantine augmentation in moderate to severe obsessive-compulsive disorder
Atieh Modarresi,Samira Chaibakhsh,Neda Koulaeinejad,Shahram Rafieian Koupaei
Psychiatry Research.2019;282(4)112602
[DOI]
8A systematic review and meta-analysis: Memantine augmentation in moderate to severe obsessive-compulsive disorder
Ricky A. Sachdev,Risha Ruparelia,Jemma E. Reid,Davis Mpavenda,Eduardo Cinosi,Naomi A. Fineberg
Psychiatry Research.2019;282(4)183
[DOI]
  Feedback 
  Subscribe